Status:
COMPLETED
QbTest Utility for Optimising Treatment in ADHD (QUOTA)
Lead Sponsor:
Nottinghamshire Healthcare NHS Trust
Conditions:
ADHD
Eligibility:
All Genders
6-17 years
Phase:
NA
Brief Summary
Attention Deficit/Hyperactivity Disorder (ADHD) is a condition that affects 3-5% of young people under 18-years-old. Young people with ADHD have difficulties with attention, impulsivity and hyperacti...
Detailed Description
The primary objective of the study is to assess the feasibility and acceptability of the study design using a feasibility RCT. The end-points to assess this objective are: * Acceptability of randomi...
Eligibility Criteria
Inclusion
- Male or Female, aged 6-17 years (at the time of consent).
- Participant is willing and able to give informed consent for participation in the study (if over 16-years).
- Parental consent for children and young people aged under 16-years-old.
- Referred to CAMHS or Community Pediatric services and diagnosed with ADHD.
- Clinician and family (parent/carer and young person/child) agreement to commence stimulant medication for ADHD symptoms.
Exclusion
- Unable to give informed consent
- Severe learning difficulty
- Not started on stimulant medication (either not started on medication at all or started on a non-stimulant medication)
- Non-fluent English
Key Trial Info
Start Date :
December 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2018
Estimated Enrollment :
43 Patients enrolled
Trial Details
Trial ID
NCT03368573
Start Date
December 1 2017
End Date
October 31 2018
Last Update
March 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nottinghamshire Healthcare NHS Foundation Trust
Nottingham, United Kingdom, NG3 6AA